The Pediatric Cancer Program participates in the Children's Oncology Group, which is supported by the National Cancer Institute. The Children's Oncology Group is the largest pediatric cooperative clinical trials group, with over 240 participating hospitals worldwide.
The primary objective of the Children's Oncology Group is to conduct clinical trials and ensure that children have access to high-quality medical care. Their mission is to cure and prevent childhood and adolescent cancer through scientific discovery and compassionate care.
The Pediatric Cancer Program has 35 Children's Oncology Group clinical trials open for the treatment of pediatric malignancies. A clinical trial is a research study performed to improve treatment. Today's standard treatment regimens are the result of knowledge gained from past clinical trials.
Currently, more than 75% of children with cancer are cured. Organized clinical trials have played a large role in the success of pediatric cancer treatment.
To learn more or to search for a clinical trial for which your child might qualify, see our Clinical Trials section.